文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

机器学习预测胶质瘤患者与铜死亡相关的 lncRNAs 和生存。

Machine learning predicts cuproptosis-related lncRNAs and survival in glioma patients.

机构信息

Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

Department of Neurosurgery, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, Guangdong, China.

出版信息

Sci Rep. 2024 Sep 27;14(1):22323. doi: 10.1038/s41598-024-72664-w.


DOI:10.1038/s41598-024-72664-w
PMID:39333603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11437180/
Abstract

Gliomas are the most common tumor in the central nervous system in adults, with glioblastoma (GBM) representing the most malignant form, while low-grade glioma (LGG) is a less severe. The prognosis for glioma remains poor even after various treatments, such as chemotherapy and immunotherapy. Cuproptosis is a newly defined form of programmed cell death, distinct from ferroptosis and apoptosis, primarily caused by the accumulation of the copper within cells. In this study, we compared the difference between the expression of cuproptosis-related genes in GBM and LGG, respectively, and conducted further analysis on the enrichment pathways of the exclusive expressed cuproptosis-related mRNAs in GBM and LGG. We established two prediction models for survival status using xgboost and random forest algorithms and applied the ROSE algorithm to balance the dataset to improve model performance.

摘要

神经胶质瘤是成人中枢神经系统最常见的肿瘤,其中胶质母细胞瘤(GBM)是最恶性的形式,而低级别神经胶质瘤(LGG)则较为良性。即使经过化疗和免疫治疗等各种治疗,神经胶质瘤的预后仍然较差。铜死亡是一种新定义的细胞程序性死亡形式,与铁死亡和细胞凋亡不同,主要是由于细胞内铜的积累引起的。在这项研究中,我们比较了 GBM 和 LGG 中铜死亡相关基因表达的差异,并对 GBM 和 LGG 中独特表达的铜死亡相关 mRNAs 的富集途径进行了进一步分析。我们使用 xgboost 和随机森林算法建立了两个生存状态预测模型,并应用 ROSE 算法对数据集进行平衡,以提高模型性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/65449a614e06/41598_2024_72664_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/0d4e16dcf4b8/41598_2024_72664_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/67669c28d138/41598_2024_72664_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/82edadcfabfb/41598_2024_72664_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/7559bbed7991/41598_2024_72664_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/b7131a8e976d/41598_2024_72664_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/0efbca974e04/41598_2024_72664_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/65449a614e06/41598_2024_72664_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/0d4e16dcf4b8/41598_2024_72664_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/67669c28d138/41598_2024_72664_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/82edadcfabfb/41598_2024_72664_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/7559bbed7991/41598_2024_72664_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/b7131a8e976d/41598_2024_72664_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/0efbca974e04/41598_2024_72664_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d419/11437180/65449a614e06/41598_2024_72664_Fig7_HTML.jpg

相似文献

[1]
Machine learning predicts cuproptosis-related lncRNAs and survival in glioma patients.

Sci Rep. 2024-9-27

[2]
Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.

Medicine (Baltimore). 2021-10-1

[3]
A cuproptosis-based prognostic model for predicting survival in low-grade glioma.

Aging (Albany NY). 2024-5-9

[4]
Transcriptional expression of ZICs as an independent indicator of survival in gliomas.

Sci Rep. 2021-9-2

[5]
LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.

Genes (Basel). 2024-4-11

[6]
Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.

Sci Rep. 2019-3-14

[7]
Identification of potential biomarkers related to glioma survival by gene expression profile analysis.

BMC Med Genomics. 2019-3-20

[8]
Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment.

Cancer Biomark. 2024

[9]
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.

Aging (Albany NY). 2021-6-3

[10]
Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.

J Cell Mol Med. 2024-6

引用本文的文献

[1]
A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches.

Clin Epigenetics. 2025-6-21

[2]
Multidimensional analysis reveals gene expression, cell interactions, and signaling networks in glioma and Alzheimer's disease.

Discov Oncol. 2025-2-19

[3]
Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy.

Int J Mol Sci. 2025-1-15

本文引用的文献

[1]
Advances in the mechanism of small nucleolar RNA and its role in DNA damage response.

Mil Med Res. 2024-8-8

[2]
Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation.

Pharmacol Res. 2024-8

[3]
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.

J Hematol Oncol. 2024-4-23

[4]
Interferon-α stimulates DExH-box helicase 58 to prevent hepatocyte ferroptosis.

Mil Med Res. 2024-4-15

[5]
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.

Mil Med Res. 2023-7-17

[6]
A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments.

Front Pharmacol. 2023-4-10

[7]
Studies on the Therapeutic and Prognostic Biomarkers of Glioma Using a Novel Cuproptosis-Related IncRNA Signature and Validation in Glioma.

J Environ Pathol Toxicol Oncol. 2023

[8]
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma.

Front Oncol. 2023-1-26

[9]
Systematic analysis of brain and skull ischemic injury expression profiles reveals associations of the tumor immune microenvironment and cell death with ischemic stroke.

Front Immunol. 2022

[10]
Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics.

Front Genet. 2022-10-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索